[1]塔娜,谭明生,移平,等.异补骨脂素对小鼠胚胎前成骨细胞胶原的影响[J].中国中医药信息杂志,2011,18(4):23-25.[doi:10.3969/j.issn.1005-5304.2011.04.010]
 TA Na,TAN Ming-sheng,YI Ping,et al.Effect of Isopsoralen on Osteoporosis Collagen of Mouse Preosteoblasts[J].zhongguo zhongyiyao xinxi zazhi,2011,18(4):23-25.[doi:10.3969/j.issn.1005-5304.2011.04.010]
点击复制

异补骨脂素对小鼠胚胎前成骨细胞胶原的影响

参考文献/References:

[1] 郭世绂,罗先正,邱贵兴.骨质疏松基础与临床[M].天津:天津科学技术出版社,2001:5.

[2] Marotta M, Martino G. Sensitive spectrophotometric method for the quantitative estimation of collagen[J]. Anal Biochem, 1985,150(1):86-90.

[3] Sassone-Corsi P, Lamph WW, Kamps M, et al. fos-associated cellular p39 is related to nuclear transcription factor AP-1[J]. Cell,1988,54(4):553-560.

[4] Eferl R, Wagner EF. AP-1:a double-edged sword in tumorigenesis[J]. Nature Reviews Cancer,2003,3:859-868.

[5] Baiyong Li, Tournier C, Davis RJ, et al. Regulation of IL-4 expression by the transcription factor junB during T helper cell differentiation[J]. EMBO Journal,1999,18:420-432.

[6] Freire G, Ocampo C, llbawi N, et al. Overt expression of AP-1 reduces alpha myosin heavy chain expression and contributes to heart failure from chronic volume overload[J]. J Mol Cell Cardiol,2007,43(4):465-478.

[7] Marusina AI, Burgess SJ, Pathmanathan I, et al. Regulation of human DAP10 gene expression in NK and T cells by AP-1 transcription factors[J]. J Immunol,2008,180:409-417.

[8] Eferl R, Ricci R, Kenner L, et al. Liver tumor development:c-jun antagonizes the proapoptotic activity of p53[J]. Cell,2003, 112(2):181-192.

[9] Wu JB, Fong YC, Tsai HY, et al. Naringin-induced bone morphogenetic protein-2 expression via PI3K, Akt,c-Fos/c-Jun and AP-1 pathway in osteoblasts[J]. Eur J Pharmacol,2008,588(2/3):333-341.

[10] EF Wagner. Functions of AP1 (Fos/Jun) in bone development[J]. Anne Rheum Dis,2002,61(Suppl-2):1140-1142.

[11] Palcy S, Boliyar I, Goltzman D. Role of activator protein 1 transcriptional activity in the regulation of gene expression by transforming growth factor beta 1 and bone morphogenetic protein 2 in ROS17/2.8 osteoblast-like cells[J]. J Bone Miner Res,2000, 15(12):2352-2361.

[12] 肖建德,阎德文.阿仑膦酸钠治疗绝经后骨

相似文献/References:

[1]唐海英,王冬春,檀爱民,等.仙灵强骨口服液对去势老龄大鼠骨质疏松症的预防作用[J].中国中医药信息杂志,2007,14(2):26.
 TANG Hai-ying,WANG Dong-chun,TAN Ai-min,et al.Preventive Effect of Xianlingqianggukoufuye on Postmenopausal Osteoporosis in Ovariectomized Rats[J].zhongguo zhongyiyao xinxi zazhi,2007,14(4):26.
[2]胡静,郑洪新.益肾填精、补钙壮骨中药复方对骨形成蛋白-4诱导成骨信号转导机制的调控作用[J].中国中医药信息杂志,2009,16(10):27.
 HU Jing,ZHENG Hong-xin.Regulating Effect of Enriching Kidney Essence and Complementing Calcium to Strengthen Bone on BMP-4 Inducing Signal Transduction[J].zhongguo zhongyiyao xinxi zazhi,2009,16(4):27.
[3]李先端,程立平,顾雪竹,等.盐补骨脂饮片质量标准研究[J].中国中医药信息杂志,2008,15(4):51.
 LI Xian-duan,CHENG Li-ping,GU Xue-zhu,et al.Study on Quality Standards of Prepared Slices of Salt-processed Psoralea Corylifolia[J].zhongguo zhongyiyao xinxi zazhi,2008,15(4):51.
[4]徐晓明,徐大勇,邢俊波.HPLC法测定补肾健脑软胶囊中补骨脂素和异补骨脂素的含量[J].中国中医药信息杂志,2008,15(7):47.
 XU Xiao-ming,XU Da-yong,XING Jun-bo.Determination of Psoralen and Isopsoralen in Bushen Jiannao Soft Capsule by HPLC[J].zhongguo zhongyiyao xinxi zazhi,2008,15(4):47.
[5]郭海英,马俊岭,阳晓东,等.中药对骨质疏松症患者骨密度的影响[J].中国中医药信息杂志,2011,18(6):74.[doi:10.3969/j.issn.1005-5304.2011.06.034]
 [J].zhongguo zhongyiyao xinxi zazhi,2011,18(4):74.[doi:10.3969/j.issn.1005-5304.2011.06.034]
[6]任路,郑洪新,林庶茹,等.纳米钙补肾中药对骨质疏松症大鼠肠黏膜中CaBP-D9K的mRNA和蛋白表达的影响[J].中国中医药信息杂志,2006,13(8):30.
 REN Lu,ZHENG Hong-xin,LIN Shu-ru,et al.Effect of Nanometer Calcium Combined with Tonifying Kidney Herbs the Expression of CaBP-D9K mRNA and Protein in the Intestinal Mucosa of Osteoporosis Rats Due to Kidney Deficiency [J].zhongguo zhongyiyao xinxi zazhi,2006,13(4):30.
[7]关俭,唐洁凤,郭光荣,等.六味地黄丸对绝经后骨质疏松患者骨密度的干预作用[J].中国中医药信息杂志,2006,13(12):70.
 [J].zhongguo zhongyiyao xinxi zazhi,2006,13(4):70.
[8]任艳玲,郑洪新,杜松,等.密骨颗粒防治去卵巢大鼠骨质疏松症作用的研究[J].中国中医药信息杂志,2005,12(4):34.
 REN Yan-ling,ZHENG Hong-xin,DU Song,et al.Experimental Research of the Function of the Migukeli in Preventing and Treating the Osteoporosis Rat Due to Ovariectomy[J].zhongguo zhongyiyao xinxi zazhi,2005,12(4):34.
[9]熊鹏程,蔡斌,黄亮.从“脏虚络痹”论骨质疏松症[J].中国中医药信息杂志,2005,12(4):90.
 [J].zhongguo zhongyiyao xinxi zazhi,2005,12(4):90.
[10]刘振峰,高振,艾力江·阿斯拉,等.新疆慢性阻塞性肺疾病继发骨质疏松症中医证候研究[J].中国中医药信息杂志,2012,19(11):13.[doi:10.3969/j.issn.1005-5304.2012.11.006]
 LIU Zhen-feng,GAO Zhen,Ailijiang Asila,et al.TCM Syndromes of Osteoporosis Secondary to Chronic Obstructive Pulmonary Disease in Xinjiang[J].zhongguo zhongyiyao xinxi zazhi,2012,19(4):13.[doi:10.3969/j.issn.1005-5304.2012.11.006]

备注/Memo

基金项目:首都医学发展基金(2002-3076);中日友好医院院内配套资金

更新日期/Last Update: